Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gag–Pol polyprotein is a large, multifunctional precursor protein encoded by the HIV-1 genome. It is essential for virion assembly, maturation, and reverse transcription. Cleavage of Gag–Pol by the viral protease is required to produce mature, infectious viral particles. It mediates binding to the plasma membrane, protein-protein interactions necessary for creating spherical particles, recruitment of viral Env proteins, and packaging of genomic RNA via direct interaction with the RNA packaging sequence (Psi).
Targeted by protease inhibitors to prevent cleavage into mature proteins; reverse transcriptase inhibitors to inhibit DNA synthesis; integrase inhibitors to prevent integration of viral DNA into the host genome
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gag–Pol polyprotein (Pr160Gag-Pol).